Form 8-K - Current report:
SEC Accession No. 0000950170-25-042660
Filing Date
2025-03-20
Accepted
2025-03-20 16:10:11
Documents
12
Period of Report
2025-03-20
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-20250320.htm   iXBRL 8-K 49245
2 EX-99.1 asmb-ex99_1.htm EX-99.1 207396
  Complete submission text file 0000950170-25-042660.txt   389666

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asmb-20250320.xsd EX-101.SCH 30676
15 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20250320_htm.xml XML 4710
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 25756523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)